11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2008
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Plant foods and estrogen receptor {alpha} and {beta} defined breast cancer: observations from the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
(
- Contribution to journal › Article
-
Mark
Diet and body constitution in relation to sub-groups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.
(
- Contribution to journal › Article
- 2005
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »